Peter Smibert

Peter Smibert is the VP of functional genomics at Immunai, a NYC-based biotechnology company. He performed his PhD research at the Australian National University and studied mechanisms of post-transcriptional gene regulation during his post-doc at Memorial Sloan-Kettering Cancer Center in New York. Prior to joining Immunai, he led the Technology Innovation Lab at the New York Genome Center. At NYGC his team focused on single cell genomics, with emphasis on building tools to obtain multiple modalities of information from high-throughput single cell assays.